ISSN: 2995-8067 | Quick Google Scholar
Organised by 
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
Our focus is to create a space where fields overlap and new knowledge can be discovered.
Infectious Diseases are caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, which can spread directly or indirectly from one individual to another. This critical field in medicine focuses on the prevention, diagnosis, treatment, and management of diseases such as influenza, tuberculosis, HIV/AIDS, and emerging global threats like COVID-19. Infectious disease specialists play a pivotal role in controlling outbreaks, understanding antimicrobial resistance, and developing vaccines and novel therapeutics.
Ongoing advancements in diagnostics, immunology, and microbiology continue to enhance the ability to combat infectious diseases. This dynamic field fosters interdisciplinary collaboration across public health, epidemiology, and clinical medicine to address complex challenges. Innovations in vaccine development, pathogen genomics, and global health strategies remain vital for improving outcomes and safeguarding communities worldwide.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
現在トレンドになっている記事はどれですか？
